Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.

Kathryn T MaplesAjay K NookaVikas GuptaNisha S JosephLeonard T HeffnerCraig HofmeisterMadhav DhodapkarShannon M MatulisSagar LonialLawrence H BoiseJonathan L Kaufman

Published in: American journal of hematology (2020)

Keyphrases

end stage renal disease
multiple myeloma
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
patient reported